Spots Global Cancer Trial Database for A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Official Title: An Open-Label, Multicenter, Long-term Treatment Extension Study in Subjects Who Have Completed a Prior GlaxoSmithKline/TESARO-Sponsored Niraparib Study and Are Judged by the Investigator to Benefit From Continued Treatment With Niraparib
Study ID: NCT04641247
Interventions
Study Description
Brief Summary: This is a global extension study to provide continued access to niraparib and further characterize the long-term safety of niraparib treatment in participants who are currently receiving treatment with niraparib within GlaxoSmithKline/TESARO-sponsored studies (NCT01847274, NCT02354586, NCT01905592, NCT03308942, NCT02657889) that has fulfilled the requirements for the primary objective.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Tucson, Arizona, United States
GSK Investigational Site, West Hollywood, California, United States
GSK Investigational Site, Whittier, California, United States
GSK Investigational Site, Jacksonville, Florida, United States
GSK Investigational Site, Atlanta, Georgia, United States
GSK Investigational Site, Harvey, Illinois, United States
GSK Investigational Site, Boston, Massachusetts, United States
GSK Investigational Site, Morristown, New Jersey, United States
GSK Investigational Site, Lake Success, New York, United States
GSK Investigational Site, Charlotte, North Carolina, United States
GSK Investigational Site, Cleveland, Ohio, United States
GSK Investigational Site, Graz, , Austria
GSK Investigational Site, Wien, , Austria
GSK Investigational Site, Vancouver, British Columbia, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Montreal, Quebec, Canada
GSK Investigational Site, Odense, , Denmark
GSK Investigational Site, Nantes cedex, , France
GSK Investigational Site, Nice Cedex 2, , France
GSK Investigational Site, Haifa, , Israel
GSK Investigational Site, Cremona, Lombardia, Italy
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Marid, , Spain
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
